Chronic Inflammatory Demyelinating Polyradiculoneuropathy in the Internal Medicine Setting

A supplement to Internal Medicine News. This supplement was supported by Talecris Biotherapeutics.

•Topics
•Faculty/Faculty Disclosures

To view the supplement, click the image above.

•Clinical Scenario

•Presenting Symptoms of CIDP

•Differential Diagnosis/Concomitant Conditions

•Obtaining a Diagnosis

•Therapeutic Options

•Best Practices: Key Takeaways
Faculty/Faculty Disclosures

Faculty/Faculty Disclosures
Peter Donofrio, MD
Department of Neurology
Vanderbilt University
Nashville, Tennessee
Dr. Donofrio is a consultant for the Steering Committee of the Talecris Biotherapeutics ICE Study.

A supplement to Internal Medicine News. This supplement was supported by Talecris Biotherapeutics.

•Topics
•Faculty/Faculty Disclosures

To view the supplement, click the image above.

•Clinical Scenario

•Presenting Symptoms of CIDP

•Differential Diagnosis/Concomitant Conditions

•Obtaining a Diagnosis

•Therapeutic Options

•Best Practices: Key Takeaways
Faculty/Faculty Disclosures

Faculty/Faculty Disclosures
Peter Donofrio, MD
Department of Neurology
Vanderbilt University
Nashville, Tennessee
Dr. Donofrio is a consultant for the Steering Committee of the Talecris Biotherapeutics ICE Study.

A supplement to Internal Medicine News. This supplement was supported by Talecris Biotherapeutics.

•Topics
•Faculty/Faculty Disclosures

To view the supplement, click the image above.

•Clinical Scenario

•Presenting Symptoms of CIDP

•Differential Diagnosis/Concomitant Conditions

•Obtaining a Diagnosis

•Therapeutic Options

•Best Practices: Key Takeaways
Faculty/Faculty Disclosures

Faculty/Faculty Disclosures
Peter Donofrio, MD
Department of Neurology
Vanderbilt University
Nashville, Tennessee
Dr. Donofrio is a consultant for the Steering Committee of the Talecris Biotherapeutics ICE Study.